Mesoblast Partners With Blood and Marrow Transplant
NEW YORK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
Source: globenewswire.com
Page 2 - Steve Dabkowski News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Steve Dabkowski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Steve Dabkowski Today - Breaking & Trending Today
Jane Bell AM Appointed Chair of Mesoblast Audit and Risk Committee
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that independent Director Jane Bell AM has been appointed Chair of the Mesoblast Board Audit and Risk Committee. Ms Bell joined the Board in August 2022, and is a banking and finance lawyer with 30 years of corporate finance expertise focussing on international investment transactions in the United States, Canada, Austral
Source: yahoo.com
Mesoblast Financial Results and Corporate Update Webcast
NEW YORK, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflamm...
Source: businessinsider.com
Appendix 4C Quarterly Activity Report for Quarter Ended
NEW YORK, July 30, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
Source: globenewswire.com
Mesoblast Reports Operational and Financial Highlights for
NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
Source: globenewswire.com